Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Prostate Cancer Metastatic × Prednisolone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Prostatic Neoplasms 2 Neoplasm, Residual 2 Lymphoma 2 Prostate Cancer Metastatic 1 Myasthenia Gravis 1 Hodgkin Disease 1 Hemangioma 1 Esophageal Stenosis 1 Barrett Esophagus 1 Adrenal Insufficiency 1

Interventions

Prednisone 2 enzalutamide 1 cabazitaxel 1 Prednisolone 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02074137 2016-06-02

Evaluation of Safety of Cabazitaxel (Jevtana) in Patients With Metastatic Hormone Refractory Prostate Cancer

Sanofi

Phase 4 Completed

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡